World Cancer Assay Markets

 

USD 2,450

* Required Fields

USD 2,450

PAY BY INVOICE

Be the first to review this product

The World Genetic Cancer Assay Markets report focuses on the varying dynamics on assessing cancer susceptibility through genetic methods of testing. This report covers the hybridization technology market, the sequencing technology market, and the microarray market for cancer testing over the geographic regions of North America, Western Europe, Japan, and the rest of the world. An in-depth analysis is provided for revenue forecasts, drivers and restraints that affect current and future markets, industry challenges and strategies, competitive structure, pricing and demand analysis, and technology trends. The base year for the report is 2000 with projections forecasted out to 2007.

Table of Contents

World Cancer Assay Markets, Executive SummaryIntroductionMarket OverviewWorld Cancer Assay Markets, Hybridization Technology MarketTotal Market Overview: DefinitionsIntroductionMarket Engineering AnalysisResearch MethodologyDrivers Restraints and Technology TrendsMarket DriversMarket RestraintsTechnology TrendsDemand Product and Pricing AnalysisDemand AnalysisProduct AnalysisPricing AnalysisTotal Competitive Structure Revenue Forecasts and Market Share AnalysisTotal Competitive StructureTotal Revenue ForecastsTotal Market Share AnalysisNorth America MarketCompetitive StructureRevenue ForecastsWestern Europe MarketCompetitive StructureRevenue ForecastsJapan MarketCompetitive StructureRevenue ForecastsRest of World MarketCompetitive StructureRevenue ForecastsChallenges Strategies and AwardsChallengesStrategiesMarket Engineering Leadership Award: VysisWorld Cancer Assay Markets, Sequencing Technology MarketTotal Market Overview: DefinitionsIntroductionMarket Engineering AnalysisResearch MethodologyDrivers Restraints and Technology TrendsMarket DriversMarket RestraintsTechnology TrendsDemand Product and Pricing AnalysisDemand AnalysisProduct AnalysisPricing AnalysisTotal Competitive Structure Revenue Forecasts and Market Share AnalysisTotal Competitive StructureTotal Revenue ForecastsTotal Market Share AnalysisNorth America MarketCompetitive StructureRevenue ForecastsWestern Europe MarketCompetitive StructureRevenue ForecastsJapan MarketCompetitive StructureRevenue ForecastsChallenges Strategies and AwardsChallengesStrategiesBusiness Development Strategy Award: Myriad GeneticsWorld Cancer Assay Markets, Microarray MarketTotal Market Overview: DefinitionsIntroductionMarket Engineering AnalysisResearch MethodologyDrivers Restraints and Technology TrendsMarket DriversMarket RestraintsTechnology TrendsDemand Product and Pricing AnalysisDemand AnalysisProduct AnalysisPricing AnalysisTotal Competitive Structure Revenue Forecasts and Market Share AnalysisTotal Competitive StructureTotal Revenue ForecastsTotal Market Share AnalysisNorth America MarketCompetitive StructureRevenue ForecastsWestern Europe MarketCompetitive StructureRevenue ForecastsJapan MarketCompetitive StructureRevenue ForecastsRest of World MarketCompetitive StructureRevenue ForecastsChallenges Strategies and AwardsChallengesStrategiesProduct Line Strategy Award: BD Biosciences ClontechWorld Cancer Assay Markets, FeedbackFeedback ProcessIntroductionFeedback Form




Keyword1

Keyword2

Keyword3

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.